#1 Clinical Trials Search in Europe

Escitalopram Oxalate

This article explores the use of Escitalopram Oxalate, also known by its brand name Lexapro, in various clinical trials. Escitalopram is an antidepressant medication belonging to the selective serotonin reuptake inhibitor (SSRI) class. These trials investigate its effectiveness in treating conditions such as depression, night eating syndrome, panic disorder, and its potential role in Alzheimer’s disease risk. We’ll examine the drug’s efficacy, safety profile, and its comparison to other treatments across different patient populations.

Table of Contents

What is Escitalopram Oxalate?

Escitalopram Oxalate is an antidepressant medication that belongs to a class of drugs called Selective Serotonin Reuptake Inhibitors (SSRIs). It is commonly known by its brand name Lexapro[1]. This medication is used to treat various mental health conditions and is available in tablet form for oral administration[2].

Conditions Treated by Escitalopram

Escitalopram is primarily used to treat the following conditions:

  • Major Depressive Disorder (MDD): This is a mental health condition characterized by persistent feelings of sadness, hopelessness, and loss of interest in daily activities[1].
  • Panic Disorder: A condition marked by sudden and repeated attacks of fear and anxiety[5].
  • Night Eating Syndrome (NES): A disorder characterized by excessive eating at night and sleep disturbances[1].
  • Depression in Multiple Sclerosis patients: Escitalopram has been studied for its effectiveness in treating depression in people with multiple sclerosis[7].
  • Perimenopausal Depression: Depression occurring during the transition to menopause[8].

How Escitalopram Works

Escitalopram works by increasing the levels of a neurotransmitter called serotonin in the brain. Serotonin is a chemical messenger that helps regulate mood, emotions, and other functions. By blocking the reuptake (reabsorption) of serotonin, escitalopram allows more serotonin to be available in the brain, which can help improve mood and reduce symptoms of depression and anxiety[1].

Dosage and Administration

The typical dosage of escitalopram for adults ranges from 10 mg to 20 mg per day, taken orally. Treatment usually starts with a lower dose (10 mg) and may be increased if necessary. It’s important to take the medication as prescribed by your healthcare provider[2][6].

Effectiveness of Escitalopram

Several studies have shown escitalopram to be effective in treating depression and anxiety disorders. For example:

  • In a study of patients with major depressive disorder, escitalopram was found to significantly reduce symptoms compared to a placebo[6].
  • Research has shown promising results in using escitalopram to treat night eating syndrome[1].
  • Studies have also explored its potential in treating depression in patients with multiple sclerosis[7].

Potential Side Effects

Like all medications, escitalopram can cause side effects. Common side effects may include:

  • Nausea
  • Dry mouth
  • Trouble sleeping
  • Fatigue
  • Increased sweating
  • Sexual side effects

It’s important to discuss any side effects with your healthcare provider. They can help determine if the benefits of the medication outweigh the risks for your specific situation[4].

Use in Special Populations

Escitalopram has been studied in various populations:

  • Elderly patients: Lower doses may be recommended for older adults.
  • Patients with multiple sclerosis: Research has explored its use in treating depression in this population[7].
  • Perimenopausal women: Studies have investigated its effectiveness in treating depression during the menopausal transition[8].

Ongoing Research

Researchers continue to study escitalopram for various conditions:

  • Its potential role in reducing the risk of Alzheimer’s disease in patients with depression[4].
  • Comparison with other treatments, such as electroacupuncture, for perimenopausal depression[8].
  • Its effectiveness in treating emotional lability (rapid, often exaggerated changes in mood) in patients with multiple sclerosis[7].
Aspect Details
Primary Conditions Studied Major Depressive Disorder, Night Eating Syndrome, Panic Disorder, Alzheimer’s Disease Risk
Dosage Range 10-20 mg daily, typically starting at 10 mg and increasing as needed
Trial Durations Varied from 8 to 12 weeks
Key Outcome Measures Hamilton Depression Rating Scale (HAM-D), Clinical Global Impression (CGI), Panic Disorder Severity Scale (PDSS), Cerebrospinal Fluid Aβ levels
Comparison Treatments Placebo, Treatment as Usual (TAU), Generic vs. Innovator Escitalopram
Special Populations Patients with Multiple Sclerosis, Advanced Cancer Patients
Safety Assessments Adverse event monitoring, Side effect burden scales

FAQ

  • What conditions is Escitalopram Oxalate being studied for in clinical trials? Escitalopram Oxalate is being studied for various conditions including major depressive disorder, night eating syndrome, panic disorder, and its potential role in Alzheimer's disease risk. It's also being investigated for depression in patients with multiple sclerosis and advanced cancer.
  • How does Escitalopram Oxalate work? Escitalopram Oxalate is a selective serotonin reuptake inhibitor (SSRI). It works by increasing the levels of serotonin, a neurotransmitter in the brain that helps maintain mental balance, potentially improving mood and reducing anxiety and depression symptoms.
  • What are some common dosages used in these clinical trials? In the clinical trials, common dosages ranged from 10 mg to 20 mg per day. Some studies started with 10 mg daily and increased to 20 mg as needed and tolerated by the patients.
  • Are there any side effects associated with Escitalopram Oxalate? While specific side effects weren't detailed in the provided trial information, SSRIs like Escitalopram can have side effects. These may include nausea, dry mouth, drowsiness, insomnia, and sexual side effects. The trials monitored for adverse events to assess the drug's safety profile.
  • How long do the clinical trials for Escitalopram Oxalate typically last? The duration of clinical trials varied depending on the study design and condition being treated. Some trials lasted 8 weeks, while others extended up to 12 weeks. Long-term studies may be conducted to assess the drug's efficacy and safety over extended periods.

Ongoing Clinical Trials on Escitalopram Oxalate

  • Study on the Effects of Escitalopram and Bupropion on Dopamine Levels in Patients with Major Depression

    Recruiting

    1 1 1 1
    Investigated diseases:
    Investigated drugs:
    Austria

  • Study on the Effects of Escitalopram, Naltrexone, and Their Combination on Reducing Symptoms of Compulsive Sexual Behavior Disorder in Affected Patients

    Recruiting

    1 1 1
    Investigated drugs:
    Poland

  • Safe Discontinuation of Antidepressants in Patients with Remitted Depression: Amitriptyline, Fluoxetine, Paroxetine, and Drug Combination Study

    Recruiting

    1 1 1 1
    Investigated diseases:
    Investigated drugs:
    Italy

  • Study on the Effects of Escitalopram, Paroxetine, and Naltrexone for Patients with Compulsive Sexual Behavior Disorder

    Not yet recruiting

    1 1 1
    Investigated drugs:
    Poland

Glossary

  • Escitalopram Oxalate: An antidepressant medication belonging to the selective serotonin reuptake inhibitor (SSRI) class, also known by the brand name Lexapro.
  • Major Depressive Disorder (MDD): A mental health condition characterized by persistently depressed mood or loss of interest in activities, causing significant impairment in daily life.
  • Night Eating Syndrome (NES): An eating disorder characterized by a delayed circadian pattern of food intake, with evening hyperphagia and/or nighttime awakenings with ingestions.
  • Panic Disorder: An anxiety disorder characterized by recurring unexpected panic attacks and persistent worry about future attacks or their consequences.
  • Bioequivalence: The property of two drug products having the same bioavailability, i.e., they produce the same therapeutic effect when administered in the same dose under similar conditions.
  • Hamilton Depression Rating Scale (HAM-D): A multiple-item questionnaire used to provide an indication of depression and as a guide to evaluate recovery.
  • Clinical Global Impression (CGI): A scale used by healthcare professionals to assess the overall severity and improvement of a patient's condition in clinical trials.
  • Amyloid Beta (Aβ): A protein fragment that accumulates in the brains of individuals with Alzheimer's disease, forming plaques that are thought to contribute to the disease process.
  • Cerebrospinal Fluid (CSF): A clear, colorless fluid that surrounds the brain and spinal cord, often used in research to measure biomarkers of neurological conditions.
  • Selective Serotonin Reuptake Inhibitor (SSRI): A class of antidepressant medications that work by increasing levels of serotonin in the brain.

References

  1. https://clinicaltrials.gov/study/NCT01401595
  2. https://clinicaltrials.gov/study/NCT01996475
  3. https://clinicaltrials.gov/study/NCT01996462
  4. https://clinicaltrials.gov/study/NCT05004987
  5. https://clinicaltrials.gov/study/NCT05737511
  6. https://clinicaltrials.gov/study/NCT00866593
  7. https://clinicaltrials.gov/study/NCT00151294
  8. https://clinicaltrials.gov/study/NCT02423694